Sector dividends NovoCure Limited
Equities
NVCR
JE00BYSS4X48
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.64 USD | -1.16% |
|
-3.81% | +5.49% |
| Jan. 14 | NovoCure Limited Presents at 44th Annual J.P. Morgan Healthcare Conference, Jan-14-2026 09:45 AM | |
| Jan. 12 | NovoCure Reports Rise in Q4 Preliminary Revenue | MT |
Main competitors
| Dividend Yield (N) | Dividend Yield (N+1) | P/E (N) | Price to Book (N) | EV / Sales (N) | EV / EBITDA (N) | EV / EBIT (N) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -9.77x | - | - | - | - | 1.53B | |
| -.--% | -.--% | 81.63x | 9.89x | 9.63x | 57.11x | 72.08x | 13.74B | |
| 2.21% | 2.37% | 23.58x | 1.94x | 1.96x | 10.41x | 15.4x | 6.56B | |
| 1.54% | 1.78% | 20.99x | 2.93x | 3.9x | 14.35x | 15.31x | 5.8B | |
| 0.59% | 0.73% | 42.59x | 10.95x | 13.24x | 33.22x | 36.95x | 5.1B | |
| 1.12% | 1.24% | 30.33x | 4.83x | 5.42x | 16.43x | 20.58x | 4.92B | |
| 0.97% | 1.04% | 51.59x | 15.42x | 20.71x | 36.11x | 39.11x | 1.92B | |
| 0.7% | 0.86% | 46.03x | 2.93x | - | - | - | 1.72B | |
| -.--% | -.--% | -18.06x | 3.87x | 623.36x | -75.44x | -69.02x | 1.53B | |
| 0.66% | 1.98% | 27.85x | 3.01x | - | - | - | 1.24B | |
| 2.58% | 2.82% | 19.76x | 1.43x | 1.82x | 7.39x | 10.42x | 1.12B | |
| -.--% | -.--% | -32.15x | 4.24x | 3.16x | 103.06x | -24.53x | 738M | |
| 1.87% | 2.31% | 27.57x | 2.85x | - | - | - | 611M | |
| Average | 1.02% | 1.26% | 24.00x | 5.36x | 75.91x | 22.52x | 12.92x | 3.58B | |
| Weighted average by Cap. | 0.89% | 1.03% | 41.90x | 6.58x | 30.48x | 29.55x | 34.57x |
- Stock Market
- Equities
- NVCR Stock
- Sector NovoCure Limited
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
